BioLegend Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioLegend's estimated annual revenue is currently $128.2M per year.(i)
  • BioLegend's estimated revenue per employee is $155,000

Employee Data

  • BioLegend has 827 Employees.(i)
  • BioLegend grew their employee count by 0% last year.

BioLegend's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
VP FinanceReveal Email/Phone
3
VP, OperationsReveal Email/Phone
4
SVP Business OperationsReveal Email/Phone
5
Head Research And Development Adm. Cell AnalysisReveal Email/Phone
6
VP Marketing & Scientific ApplicationsReveal Email/Phone
7
VP Human ResourcesReveal Email/Phone
8
VP Research And DevelopmentReveal Email/Phone
9
Head Software and Data Science - Scientific ApplicationsReveal Email/Phone
10
Director, ProtegenomicsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is BioLegend?

BioLegend develops world-class, cutting-edge antibodies, recombinant proteins, bioassays, and other reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, California. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support. BioLegend was incorporated in June, 2002. The founder and CEO of BioLegend, Gene Lay, D.V.M., who was also the co-founder of PharMingen.

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

827

Number of Employees

$128.2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioLegend News

2022-04-20 - RNPS1 inhibits excessive tumor necrosis factor/tumor ...

2 (Biolegend, clone 104)]. Detection of Apoptosis. Annexin V labeling and detection were performed with the fluorescein isothiocyanate–annexin V...

2022-04-17 - Amyloid Peptides Market Size, Scope And Forecast ...

AmideBio, Cambridge Research Biochemicals, BioLegend, AnaSpec, rPeptide, Genscript, Bio-Synthesis, NovoPro Inc., Bachem.

2022-03-22 - Fitch Affirms PerkinElmer at 'BBB'; Outlook Stable

The affirmation following PKI's eight acquisitions in 2021, notably BioLegend which incurred $2.9 billion in additional debt,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$258.7M840N/AN/A
#2
$15M8455%N/A
#3
$196.6M8519%N/A
#4
$167.8M8561%N/A
#5
$518.9M86924%N/A